UniQure, after setbacks, seeks FDA approval of Huntington’s gene therapy
UniQure, after setbacks, seeks FDA approval of Huntington’s gene therapy BioPharma Dive
Finance, IT & News
UniQure, after setbacks, seeks FDA approval of Huntington’s gene therapy BioPharma Dive
FDA approves Zimrixby (rituximab) and Garzulys (insulin aspart) biosimilars Generics and Biosimilars Initiative
Mounjaro: FDA Approves GLP-1 for Cardiovascular Risk Reduction Healthline
FDA Approval of Essential Thrombocythemia Drug is “Important Milestone” CancerNetwork
FDA Approves Updated COVID-19 Vaccines for 2026-2027 respiratory-therapy.com